DTNBP1 and brain neoplasm: Despite preliminary evidence to suggest dysbindin involvement in cognitive function in patients with brain tumours (Correa et al., 2016), there is a paucity of studies examining the role of dysbindin in other neurological and neuropsychiatric disorders where symptoms include cognitive dysfunction.